Bill
Bill > S1187
NJ S1187
NJ S1187Mandates health benefits coverage for preimplantation genetic screening under certain health insurance plans.
summary
Introduced
01/31/2022
01/31/2022
In Committee
01/31/2022
01/31/2022
Crossed Over
Passed
Dead
01/08/2024
01/08/2024
Introduced Session
2022-2023 Regular Session
Bill Summary
This bill amends the current law concerning insurance coverage for infertility treatment and services. It requires certain health insurers to provide health benefits coverage for preimplantation genetic screening when it is considered a medically necessary expense incurred in the diagnosis and treatment of infertility, as defined under that law. Under the bill, "preimplantation genetic screening" means a laboratory procedure that is used in conjunction with in vitro fertilization (IVF) to test an embryo for abnormal chromosomes before it is transferred to the uterus. Compared to transferring multiple embryos without preimplantation genetic screening, research indicates that transferring a single embryo with no chromosomal abnormalities during an IVF cycle has a decreased probability of resulting in a medically expensive and risky multiple gestation pregnancy without affecting the potential success of the cycle. Furthermore, transferring embryos without chromosomal abnormalities also significantly decreases the probability of a miscarriage. The infertility coverage law currently includes health benefits for IVF; however, health insurers are permitted under that law to limit IVF benefits to a covered person who: has used all reasonable, less expensive and medically appropriate treatments and is still unable to become pregnant or carry a pregnancy; has not reached the limit of four completed egg retrievals; and is 45 years of age or younger. Under this bill, the same limitations may apply to preimplantation genetic screening at the discretion of the health insurer. The provisions of this bill apply to hospital, medical and health service corporations, commercial group insurers and health maintenance organizations that provide benefits to groups of 50 or more persons. The bill also applies to health benefits plans issued pursuant to the State Health Benefits Program and the School Employees' Health Benefits Program.
AI Summary
This bill amends the current law concerning insurance coverage for infertility treatment and services. It requires certain health insurers to provide health benefits coverage for preimplantation genetic screening when it is considered a medically necessary expense incurred in the diagnosis and treatment of infertility. Preimplantation genetic screening is a laboratory procedure used in conjunction with in vitro fertilization to test an embryo for abnormal chromosomes before it is transferred to the uterus. Transferring a single embryo with no chromosomal abnormalities has a decreased probability of resulting in a multiple gestation pregnancy compared to transferring multiple embryos without preimplantation genetic screening, without affecting the potential success of the cycle. The bill also allows insurers to limit preimplantation genetic screening benefits to covered persons who have used all reasonable, less expensive and medically appropriate treatments and are still unable to become pregnant or carry a pregnancy, have not reached the limit of four completed egg retrievals, and are 45 years of age or younger.
Committee Categories
Business and Industry
Sponsors (1)
Last Action
Introduced in the Senate, Referred to Senate Commerce Committee (on 01/31/2022)
Bill Topics
Health
- ‐ Health Insurance Reform
- ‐ Maternal Health
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location | Created |
|---|---|---|
| State Bill Page | https://www.njleg.state.nj.us/bill-search/2022/S1187 | 01/28/2022 |
| BillText | https://www.njleg.state.nj.us/Bills/2022/S1500/1187_I1.HTM | 02/01/2022 |
| Bill | https://www.njleg.state.nj.us/Bills/2022/S1500/1187_I1.PDF | 02/01/2022 |
Loading...